About Us

Ambix is a series of funds founded in 2019 by a team with deep domain experience in creating, operating, advising and funding life science startups. We create, grow and invest in privately held, high growth life science companies, including diagnostic and therapeutic devices and tools, biochemistry sensors, consumables, digital health applications and other highly differentiated, innovative medical and healthcare technologies. We focus on companies that can commercialize quickly with optimal resource allocation, adapt to a rapidly changing regulatory environment, and innovate in a capital efficient manner. Our portfolio companies come from a broad array of industry segments within healthcare, including neurovascular, cardiovascular, in vitro diagnostics and diabetes and metabolic disease care, and blur the line between traditional medical devices and consumer products. We expect to invest in technologies that don’t exist today. Many of our portfolio companies will leverage “crossover” technologies such as machine learning, Internet of Things, artificial intelligence, sensors and computational science, to provide new or superior benefits to patients and providers more quickly and cost effectively. We only target opportunities with transformative ideas and the potential for high growth.

Ambix is not traditional Silicon Valley venture capital. We have all the advantages of traditional venture – including domain expertise and a global network of connections to resources and deal flow. We also have extensive operating experience to enable critical “hands on” management of our portfolio companies. But unlike traditional venture capital, we have exclusive access to new technologies and technical and administrative services through our partnership with the Silicon Valley medical device incubator Alembic, LLC. We not only invest, we also create.